Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival

Journal of Neuro-Oncology

Volumn 84, Issue 3, 2007, Pages 255-261

  Peria, Fernanda M ^a   Neder, Luciano ^a   Marie, Sueli K N ^a   Rosemberg, Sergio ^a   Oba Shinjo, Sueli M ^a   Colli, Benedicto O ^a   Gabbai, Alberto A ^b   Malheiros, Suzana M F ^b   Zago, Marco A ^a   Panepucci, Rodrigo A ^a   Moreira Filho, Carlos A ^a,c   Okamoto, Oswaldo K ^c   Carlotti Jr , Carlos G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Albert Einstein Research and Education Institute   (Brazil)

Author keywords

Cellular proliferation; Glioma; Immunohistochemistry; Microarray; Microvascular density; Overall survival; Pleiotrophin

Indexed keywords

CARMUSTINE; CD31 ANTIGEN; CYTOKINE; KI 67 ANTIGEN; LOMUSTINE; PLEIOTROPHIN; PROCARBAZINE; PROTEIN ANTIBODY; VINCRISTINE;

ARTICLE; ASTROCYTOMA; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION;

ASTROCYTOMA; BRAIN NEOPLASMS; CARRIER PROTEINS; CELL PROLIFERATION; CYTOKINES; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; NEOVASCULARIZATION, PATHOLOGIC; OLIGODENDROGLIOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34547184970     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9379-2     Document Type: Article

References (26)

1. Bao X, Mikami T, Yamada S, Faissner A, Muramatsu T, Sugahara S (2005) Heparin-binding growth factor, pleiotrophin, mediates neuritogenic activity of embryonic pig brain-derived chondroitin sulfate/dermatan sulfate hybrid chains. J Biol Chem 280:9180-9191
2. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY (2002) Pleiotrophin: A cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397:162-171
3. Laaroubi K, Delbe J, Vacherot F, Desgrandes P, Tardieu M, Jaye M, Barritault D, Courty J (1994) Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors 10:89-98
4. Merenmies J, Rauvula H (1990) Molecular cloning of the 18-Kda growth-associated protein of developing brain. J Biol Chem 285:16721-16724
5. Bowden ET, Stoica GE, Wellstein A (2002) Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase. J Biol Chem 277:3582-3586
6. Jager R, List B, Knabbe C, Souttou B, Raulais D, Zeiler T, Wellstein A, Aigner A, Neubauer A, Zugmaier G (2002) Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients. Br J Cancer 86:858-863
7. Li G, Hu Y, Huo Y, Liu M, Freeman D, Gao J, Liu X, Wu D, Wu H (2006) PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin. J Biol Chem 281:10663-10668
8. Kadomatsu K, Muramatsu T (2004) Midkine and pleiotrophin in neural development and cancer. Cancer Lett 204:127-143
9. Furuta M, Shiraishi T, Okamoto H, Mineta T, Tabuchi K, Shiwa M (2004) Identification of pleiotrophin in conditioned secreted from neural stem cells by SELDI-TOF and SELDI-tandem mass spectrometry. Dev Brain Res 132:189-197
10. Jung CG, Hida H, Nakahira K, Ikenaka K, Kim HJ, Nishino N (2004) Pleiotrophin mRNA is highly expresses in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cell-derivated nestin-positive cells. FASEB J 18:1237-1239
11. Lu KV, Jong KA, Kim GY, Singh J, Dia EQ, Yoshimoto K, Wang MY, Cloughesy TF, Nelson SF, Mischel PS (2005) Differential induction of glioblastoma migration and growth by two forms of pleiotrophin. J Biol Chem 280:26953-26964
12. Moon HS, Park WI, Sung SH, Choi EA, Chung HW, Woo BH (2003) Immunohistochemical and quantitative competitive PCR analyses of midkine and pleiotrophin expression in cervical cancer. Gynecol Oncol 88:289-297
13. Muller S, Kunkel P, Lamszus K, Ulbricht U, Lorente GA, Nelson AM, von Schack D, Chin D, Lohr SC, Westphal M, Melcher T (2003) A role for tyrosine phospatase ζ in glioma cell migration. Oncogene 22:6661-6668
14. Powers C, Aigner A, Stoica GE, McDonnell K, Wellstein A (2002) Pleitrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth. J Biol Chem 277:14153-14158
15. Sanson M, Thillet J, Hoang-Xuan K (2004) Molecular changes in gliomas. Curr Opin Oncol 16:607-613
16. Wu H, Barusevicius A, Babb J, Klein-Szanto AK, Godwin A, Elentsas R, Gelfand JM, Lessin S, Seykora JT (2005) Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential. J Cutan Pathol 32:125-130
17. Souttou B, Juhl H, Hackenbruck J, Rockseisen M, Klomp HJ, Raulais D, Vigny M, Wellstein A (1998) Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors. J Nat Cancer Inst 90:1468-1473
18. Mentlein M, Held-Feindt J (2002) Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. J Neurochem 83:747-753
19. Ulbricht U, Brockmann MA, Aigner A, Eckerich C, Muller S, Fillbrandt R, Westphal M, Lamszus K (2003) Expression and function of the receptor of the protein tyrosine phosphatase ζ and its ligand pleiotrophin in human astrocytomas. J Neuropathol Exp Neurol 62:1265-1275
20. Malerczyk C, Schulte AM, Czubayko F, Bellon L, Macejak D, Riegel AT, Wellstein A (2005) Ribozyme targeting of the growth factor pleiotrophin in established tumors: A gene therapy approach. Gene Ther 12:339-346
21. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225
22. Zhang L, Mabuchi T, Satoh E, Maeda S, Nukui H, Naganuma H (2004) Over expression of heparin-binding growth-associated molecule in malignant glioma cells. Neurol Med Chir 44:637-645
23. Zhang N, Zhong R, Perez-Pinera P, Herradon G, Ezquerra L, Wang ZY, Deuel TF (2006) Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch. Biochem Biophys Res Commun 343:653-658
24. Foehr ED, Lorente G, Kuo J, Ram R, Nikolich K, Urfer R (2006) Targeting of the receptor protein tyrosine phosphatase β with a monclonal antibody delays tumor growth in a glioblastoma model. Cancer Res 66:2271-2278
25. Ulbricht U, Eckerich C, Fillbrandt R, Westphal M, Lamszus K (2006) RNA interference targeting protein tyrosine phosphatase ζ/receptor-type protein tyrosine phosphatase β supresses glioblastoma growth in vitro and in vivo. J Neurochem 98:1497-1506
26. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828